<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240518061832N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-10-17</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the effectiveness of intranasal PRF treatment compared to standard treatment on mucosal healing at the cautery site during rhinosinusitis endoscopic surgery in chronic rhinosinusitis patients</public_title>
      <acronym>PRF</acronym>
      <scientific_title>Investigating the effectiveness of intranasal PRF treatment compared to standard treatment on mucosal healing at the cautery site during rhinosinusitis endoscopic surgery in chronic rhinosinusitis patients referred to Taleghani Hospital during 1403-1405</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-10-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>61</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/79311</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: For simple randomization, the number table of Rand company's program is used, and a plan is given for intervention in each of the donor nasal cavities by the operator, and one of the cavities is randomly selected as the intervention group, and fibrin rich in platelets is included in it. The hole is placed. Also, the other hole is determined as a sample and control group. All this information is recorded by the project manager, and in order not to affect the surgical procedure, the surgeon is not informed until the end of the operation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Chronic sinusitis after endoscopic surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this study, all adult patients over 18 years of age suffering from chronic rhinosinusitis undergoing FESS surgery who referred to Taleghani Hospital from 1403 to 1405 will be examined. In this study, patients for whom electrocautery is used in two nasal cavities during FESS surgery, platelet-rich fibrin (PRF) is prepared using the patient's own venous blood, and randomly placed in one of the nasal cavities at the cautery site. Intervention 2: Control group: After one of the patient's nasal cavities was randomly selected for intervention. The other cavity of the nose is repaired in a standard way, and this cavity is considered as the control group. Then both cavities under the endoscopic guide are homeostasised and packed in the same way. With this method, the control group and the intervention are performed on one patient, which creates a better matching for this plan.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Patient information remains confidential, but results are shared with privacy and data protection

When:
always

To whom:
everyone

Conditions:
All items

Where to obtain:
Email of the responsible person

How to obtain:
Contact by phone or email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>vahid ghasem amooeian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tehran Province, Tajrish، Velenjak، 7th Floor, Bldg No.2 SBUMS, Arabi Ave</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2243 9770</telephone>
        <email>vahidvm2m@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>matin ghazi zadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>2 SBMU, Arabi Ave, Daneshjoo Blvd, Velenjak, Tehran, Iran.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 23871</telephone>
        <email>vahidvm2m@gmail.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Bilateral chronic rhinosinusitis with nasal polyps
A difference in scores of two or less LUND MACKY SCORE between both nasal cavities
Age between 18 and 60 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with unilateral nasal polyps
antrochoanal polyp
Chronic rhinosinusitis without polyps
History of nose or sinus surgery
Immunity deficiency</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this study, all adult patients over 18 years of age suffering from chronic rhinosinusitis undergoing FESS surgery who referred to Taleghani Hospital from 1403 to 1405 will be examined. In this study, patients for whom electrocautery is used in two nasal cavities during FESS surgery, platelet-rich fibrin (PRF) is prepared using the patient's own venous blood, and randomly placed in one of the nasal cavities at the cautery site.</i_keyword>
      <i_keyword>Control group: After one of the patient's nasal cavities was randomly selected for intervention. The other cavity of the nose is repaired in a standard way, and this cavity is considered as the control group. Then both cavities under the endoscopic guide are homeostasised and packed in the same way. With this method, the control group and the intervention are performed on one patient, which creates a better matching for this plan.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Determining and comparing the effectiveness of intranasal platelet-rich fibrin (PRF) treatment with standard treatment on wound healing at the cautery site during FESS surgery in chronic sinusitis patients. Timepoint: Patients 3 days after surgery and after removing tampons if any and two weeks after surgery and one month after surgery and three months after surgery in terms of shortness of breath and bleeding and endoscopic findings in terms of adhesion and wound healing and site Wounds and cautery are checked. Method of measurement: Accordingly, the following were scored by endoscopic assessment: Adhesion (0 = none, 1 = adhesion not affecting sinus drainage, 2 = moderate adhesion affecting sinus drainage, 3 = complete adhesion between the middle and lateral prongs of the nasal wall (bleeding) 0 = none; 1 = minimal, confined to nasal cavity; 3 = severe, need for cauterization (0 = minimal, 2 = moderate, 3 = severe) (0) = no infection, 1 = mild purulent mucous discharge, 2 = moderate purulent mucous discharge, 3 = severe purulent mucous discharge) granulation (0 = none, 1 = minimal, 2 = moderate, 3 = severe) also from patient questionnaire NOSE and history are taken before and after surgery and during the follow-up period. Finally, all the information is collected and then the statistical analysis of the data is done.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-09-18</approval_date>
        <contact_name>Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Tehran Province, Tajrish، Velenjak، 7th Floor, Bldg No.2 SBUMS, Arabi Ave Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
